期刊文献+

依折麦布联合氟伐他汀对冠心病患者的降脂效果观察 被引量:1

Observation Lipid-lowering Effect of Ezetimibe Combine With Fluvastatin in Patients With Coronary Heart Disease
下载PDF
导出
摘要 目的探讨依折麦布联合氟伐他汀对冠心病患者降脂的临床效果。方法将72例冠心病患者分为两组,对照组给予氟伐他汀治疗,观察组给予依折麦布联合氟伐他汀治疗,观察两组疗效。结果两组患者血脂水平临床指标相较治疗前均有所下降,P<0.05,差异具有统计学意义,同时观察组患者下降程度高于对照组,P<0.05,差异具有统计学意义。结论依折麦布联合氟伐他汀在冠心病患者降脂治疗中的应用效果显著。 Objective To explore the lipid-lowering effect of ezetimibe combine with lfuvastatin in patients with coronary heart disease.Methods Selected 72 patients with coronary heart disease were divided into two groups, the control group given lfuvastatin statin therapy, the observation group was given according to fold the ezetimibe with fluorine cut statin therapy, observed the curative effect of the two groups.ResultsTwo groups of patients with blood lipid levels in clinical indicators intersection before treatment were decreased,P〈0.05, had difference statistically signiifcance, and at the same time observation group of patients decline was higher than the control group,P〈0.05, had difference statistically significance. Conclusion According to fold the ezetimibe combine fluvastatin statins lipid-lowering therapy in patients with coronary heart disease is remarkable.
作者 杜颖 韩丽华
出处 《中国继续医学教育》 2015年第26期154-155,共2页 China Continuing Medical Education
关键词 依折麦布 氟伐他汀 冠心病 降脂 Ezetimibe Fluvastatin Coronary heart disease Blood lipid
  • 相关文献

参考文献3

二级参考文献26

  • 1孙超,宋娟,田华,赵学梅.氟伐他汀非降脂作用研究进展[J].齐齐哈尔医学院学报,2009,30(4):444-445. 被引量:2
  • 2唐慧,关林,姜国攀.强化降脂对冠心病患者的疗效及安全性[J].中国热带医学,2007,7(2):223-223. 被引量:2
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5228
  • 4中华人民共和国卫生部.2009年中国卫生统计年鉴目录:2008年城市居民主要疾病死亡率及构成[R/OL]. 2009[2011 -12].http: // www. moh. gov. cn/publicfiles//business/htmlfiles/wsb/index, htm.
  • 5K0S0GL0U T,STATKEVICH P, JOHNSON LEVONAS AO, etal. Ezetimibe: a review of its metabolism, pharmacokinetics anddrug interactions[ J] . Clin Pharmacokinet, 2005 , 44(5 ) ; 467 -494.
  • 6DAVIS H H. Ezetimibe: first in a new class of cholesterol absorp-tion inhibitors [ J ]. International Congress Series, 2004,1262 :243 -246.
  • 7PANDOR A, ARA R M, TUMUR L, et al. Ezetimibe monothera-py for cholesterol lowering in2722 people: systematic review andmeta - analysis of randomized controlled trials [ J] . Intern Med,2009, 265(5) : 568 -580.
  • 8SCHOUTEN 0,BOERSMA E,HOEKS S E, et al. Fluvastatinand perioperative events in patients undergoing vascular surgery[J]. N Engl J Med, 2009,361(10) : 980 -989.
  • 9LEE C H, DE FEYTER P,SERRUYS P W,et al. Beneficialeffects of fluvastatin following percutaneous coronary intervention inpatients with unstable and stable angina : results from the Lescolintervention prevention study ( LIPS) [ J] . Heart, 2004 , 90(10):1156-1161.
  • 10BALLANTYNE C M. Ezetimibe: efficacy and safety in clinical tri-als [ J ]. Eur Heart J SuppI,2002,4 ( Suppl J) : J9 - J18.

共引文献13

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部